Drug
Amikacin clinical trials
Also written ARIKAYCE® and Amikin.
- studies test it
- 46
- open now
- 7
- in phase 3
- 10
- first study started
- 2002
Keep track of what changes. Save the Amikacin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
43 studies that test it; most in 2012 (6); 1 more planned to start later
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 6 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 15
- Phase 3
- 10
- Phase 4
- 9
- No phase
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 31
Insmed Incorporated (13) · Assistance Publique - Hôpitaux de Paris (2) · The University of Queensland (2) · Beni-Suef University (1) · Murdoch Childrens Research Institute (1) · Postgraduate Medical Institute, Lahore (1) · University Hospital, Tours (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Often tested with
Tested in the same studies.
Imipenem (5) · Clofazimine (4) · Ceftazidime (3) · Ciprofloxacin (3) · Colistinmethanesulfonic acid (2) · Meropenem (2) · Trimethoprim, Sulfamethoxazole Drug Combination (2) · Piperacillin, Tazobactam Drug Combination (2)
Studies
Open first, then newest update. How each study uses Amikacin is read from its arms, and is right about nine times in ten.
Testing it · 46
- " Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "RecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT06602557Written as Amikacin
- Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationPhase 1Vancouver Coastal HealthNCT07228702Written as Amikacin Injection
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingPhase 2/3The University of QueenslandNCT04310930Written as Amikacin
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingPhase 2The University of QueenslandNCT07485010Written as Amikacin Injection
- Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary InfectionRecruitingPhase 2Centre Hospitalier Universitaire, AmiensNCT06585020Written as Arikayce
- A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With CirrhosisRecruitingPhase 4Asian Institute of Gastroenterology, IndiaNCT06808074Written as Inhaled amikacin
- Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant TuberculosisRecruitingPhase 2Rwanda Biomedical CentreNCT05555303Written as Amikacin
- Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.Active, not recruitingPhase 4Beni-Suef UniversityNCT07694700Written as Amikacin Injection and meropenem
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedPhase 4Murdoch Childrens Research InstituteNCT04948463Written as Amikacin Injection
- Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedPhase 3Insmed IncorporatedNCT04677569Written as ALIS
- Clinical Outcomes of Inhaled Amikacin in Ventilator Associated PneumoniaCompletedPhase 4Postgraduate Medical Institute, LahoreNCT07369336Written as Amikacin (Inhalation)
- Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated PneumoniaCompletedPhase 3University Hospital, ToursNCT03149640Written as Inhaled amikacin
- Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient PopulationTerminatedPhase 4Assistance Publique Hopitaux De MarseilleNCT02872272Written as Treatment with Amikacin
- Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedPhase 3Insmed IncorporatedNCT04677543Written as ALIS
- A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male ParticipantsCompletedPhase 1Insmed IncorporatedNCT05999942Written as Liposomal Amikacin for Inhalation
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000641Written as Amikacin sulfate
- Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™Status unknownPhase 1University Medical Center GroningenNCT04249531Written as Amikacin Injectable Product
- Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With HypothermiaStatus unknownNot applicableUniversity of SarajevoNCT04867993Written as Amikacin
- Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)CompletedPhase 1/2Insmed IncorporatedNCT00777296Written as ARIKACE™
- Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension PhaseCompletedPhase 2Insmed IncorporatedNCT03905642Written as Arikayce™
See all 46 studies that test Amikacin →
Given in every arm · 2 — Amikacin is usual care beside what is tested
- Which Apparatus for Inhaled Pentamidine?Status unknownEarly Phase 1Cliniques universitaires Saint-Luc- Université Catholique de LouvainNCT02277808Written as 500mg Amikacine (Amukin®) diluted in 4mL NaCl (0,9%)
- Neonatal Suspected Sepsis Treated With Cefazolin or VancomycinCompletedPhase 3Hospital Italiano de Buenos AiresNCT01867138Written as Amikacin
As the comparator · 3 — what is tested is compared with Amikacin
- Potentiated Aminoglycosides in Postoperative Urinary Tract Infection ProphylaxisRecruitingEarly Phase 1Centre Hospitalier Universitaire VaudoisNCT05761405Written as Amikacin
- the Incidence of Necrotizing Enterocolitis in Preterm With Respiratory Distress Syndrome Undergoing Caffeine TherapyActive, not recruitingEarly Phase 1Al-Azhar UniversityNCT06097767Written as Amikacin
- Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)CompletedPhase 2Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranNCT04209192Written as Amikacin
Codes
What other systems call Amikacin · ClinicalTrials.gg INT006943
- MeSH (NLM) D000583AmikacinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 84319SGC3CAMIKACINConfirmed FDA, NLM, Wikidata
- RxNorm 641Confirmed FDA, Wikidata
- Wikidata Q408529amikacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61615AmikacinConfirmed FDA, Wikidata
- DrugBank DB00479One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000583 | Amikacin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 84319SGC3C | AMIKACIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 641 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408529 | amikacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61615 | Amikacin | Confirmed FDA, Wikidata |
| DrugBank | DB00479 | — | One source Wikidata |
Also registered as amikacin sulfate (UNII N6M33094FD · RxNorm 643).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.